Not applicableUnknownNCT05716672What this trial is testingImpact of Lazertinib Dose Modification on Effectiveness and SafetyWho this might be right forNon-small Cell Lung Cancer Pusan National University Hospital 200
Early research (Phase 1)Study completedNCT00569712What this trial is testingStudying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and FormoterolWho this might be right forLung CancerPrecancerous Condition British Columbia Cancer Agency 30
Not applicableStudy completedNCT02805530What this trial is testingRadical Treatment of Synchronous Oligometastatic Non-Small Cell Lung CarcinomaWho this might be right forCarcinoma, Non-Small-Cell LungSynchronous Neoplasms Instituto Nacional de Cancerologia de Mexico 36
Not applicableUnknownNCT05010330What this trial is testingIdentify Prognostic Biomarkers of Lung CancerWho this might be right forLung CancerLung AdenocarcinomaLung Squamous Cell Carcinoma+1 more RenJi Hospital 500
Testing effectiveness (Phase 2)UnknownNCT04455594What this trial is testingAlmonertinib Vs. Erlotinib/Chemotherapy for Neo-adjuVant Treatment of Stage IIIA-N2 EGFR-mutated NSCLCWho this might be right forNon-Small Cell Lung Cancer Stage IIIA The First Affiliated Hospital of Guangzhou Medical University 168
Testing effectiveness (Phase 2)Study completedNCT02576431What this trial is testingTest the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsWho this might be right forSolid Tumors Harboring NTRK Fusion Bayer 215
Large-scale testing (Phase 3)Active Not RecruitingNCT05502237What this trial is testingZimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Gilead Sciences 1,021
Testing effectiveness (Phase 2)Study completedNCT00147537What this trial is testingCombination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Pfizer 282
Not applicableUnknownNCT02663492What this trial is testingTranscutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer PatientsWho this might be right forNon-Small Cell Lung CancerLung Cancer Tongji University 300
Testing effectiveness (Phase 2)Study completedNCT00137839What this trial is testingErlotinib in Women With Previously Untreated Adenocarcinoma of the LungWho this might be right forAdenocarcinomaNon-small Cell Lung Cancer Pasi A. Janne, MD, PhD 84
Testing effectiveness (Phase 2)Study completedNCT00041028What this trial is testingEF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerWho this might be right forLung Cancer Duke University 60
Large-scale testing (Phase 3)Study completedNCT00017407What this trial is testingCarboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung CancerWho this might be right forLung Cancer Ionis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT02797964What this trial is testingA Phase 1/2 Trial of SRA737 in Subjects With Advanced CancerWho this might be right forAdvanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL) Sierra Oncology LLC - a GSK company 107
Not applicableLooking for participantsNCT07696832What this trial is testingEfficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort StudyWho this might be right forPatients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLCEGFR Mutation-negative and ALK Rearrangement-negativeEastern Cooperative Oncology Group Performance Status (ECOG PS) Score of 0 to 2+2 more Guangdong Association of Clinical Trials
Early research (Phase 1)Ended earlyNCT04348292What this trial is testingSirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung CancerWho this might be right forLung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+7 more Emory University 3
Not applicableActive Not RecruitingNCT07262671What this trial is testingPredictive Value of Exosomes in Pleural Effusion for Advanced Lung CancerWho this might be right forNSCLC (Advanced Non-small Cell Lung Cancer) Fudan University 100
Not applicableLooking for participantsNCT05498064What this trial is testingA Real World Study of Ensartinib in Advanced ALK-positive NSCLCWho this might be right forCarcinoma, Non-Small-Cell LungAnaplastic Lymphoma Kinase I1171NEnsartinib Peking Union Medical College Hospital 490
Post-approval studies (Phase 4)Study completedNCT03285763What this trial is testingAtezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)Who this might be right forCarcinoma, Non-Small-Cell Lung Hoffmann-La Roche 619
Early research (Phase 1)Study completedNCT04006301What this trial is testingFirst-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C MutationWho this might be right forNeoplasmsAdvanced Solid TumorsNon-small Cell Lung Cancer+1 more Janssen Research & Development, LLC 10
Testing effectiveness (Phase 2)Ended earlyNCT04422392What this trial is testingNeoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Shanghai Pulmonary Hospital, Shanghai, China 93